Please tell us about yourself.

 I grew up in Billings, Montana, and I am blessed with an amazing wife and 4 incredible children. I enjoy golfing, fly fishing, and working on old cars/trucks. I joined the US Navy in 1995 and retired in 2015 and started my Navy career in the Navy nuclear power program. After 7 years in nuclear power, I transferred to Navy Radiation Health and worked as a Health/Medical Physicist. My medical interests include cancer imaging, radioactive microspheres, and advancing MRI and nuclear medicine.

 Give us your background information related to your professional training, including nuclear medicine, and what inspired you to enter this field.

I completed a BS degree in Physics from Montana State University, a MA in Educational Leadership from George Washington University, and PhD in Medical Physics from the University of Wisconsin. I am board certified by the ABR in Diagnostic Medical Physics. My dissertation research centered on patient-specific dosimetry for radioactive microspheres used for treating liver cancer. I was inspired to join nuclear medicine due to my background and experience in nuclear power and my desire to advance cancer treatment through radiation treatment. I was fortunate to obtain deep experiences in dosimetry at the Navy Dosimetry Center as Science and Research Advisor, clinical nuclear medicine and medical physics at Bethesda Naval Hospital, preclinical and clinical imaging research and grant writing at Uniformed Services University Radiology Department, and internal monitoring and dosimetry as Technical Advisor to the DOD for Operation Tomodachi which provided humanitarian and disaster support following a tsunami and Fukushima nuclear disaster.

 What do you consider your primary contribution(s) to Nuclear Medicine?

 While completing my dissertation, I spent years measuring the miniscule positron emission from yttrium-90. The results were published in 2007 and provided the most precise measurement of the Y90 positron branching ratio to date which significantly increased the precision of Y90 PET-based dosimetry calculations. This work has generated efforts to improve Y90 radiomicrosphere dosimetry and patient outcomes.

 In what year were you a SWC-SNMMI President, and how did you first become involved with the chapter?

 I served as SWC-SNMMI president from April 2019 to April 2020. I was the Program Chair for the 61st Annual SWC-SNMMI meeting and served on the Board from 2016-2018.

 Please describe anything else that you would like for your Nuclear Medicine colleagues to know about yourself.

 I am honored to serve the SWC-SNMMI and have made lifelong friends and met several new colleagues, and I look forward to the annual meeting.